Tryptase Promotes Atherosclerotic Plaque Haemorrhage in ApoE-/- Mice

Tryptase, the most abundant mast cell (MC) granule protein, plays an important role in atherosclerosis plaque development. To test the hypothesis that tryptase participates directly in atherosclerosis plaque haemorrhage, the gene sequence and siRNA for tryptase were cloned into a lentivirus carrier and atherosclerosis plaque haemorrhage models in ApoE-/- mice were constructed. After a cuffing-cervical artery operation, the mice were randomly divided into 6 groups. Hematoxylin and eosin(HE) staining showed that the cervical artery plaque area was much larger in the tryptase overexpression group compared to the other groups, and there was greater artery stenosis. The artery stenosis from the cuff-side in all groups was more than 90%, except the siRNA group. Tryptase promotes plaque haemorrhage distinctively because 50% of the mice in the tryptase overexpression group had plaque haemorrhage, while only 10% in the siRNA group did. The immunohistochemistry of the cervical artery plaque showed that plasminogen activator inhibitor-1 (PAI-1) expression was the lowest while tissue plasminogen activator (tPA), CD31, CD34 and VEGF was the highest in the tryptase overexpression groups. This observation was completely contrary to what was observed in the siRNA group. Tryptase promoted bEnd.3 cell growth, migration and capillary-like tube formation, which suggests that tryptase can promote microvessel angiogenesis. PAI-1 expression was inhibited, while tPA expression was increased by tryptase in bEnd.3 cells. Our in vivo and in vitro studies suggest that trypase can promote atherosclerotic plaque haemorrhage by promoting angiogenesis and regulating the balance of PAI-1 and tPA. Thus, regulating tryptase expression in MCs may provide a potential target for atherosclerosis treatment.

[1]  N. Mackman,et al.  Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[2]  I. Bot,et al.  Mast cells in atherosclerosis , 2011, Thrombosis and Haemostasis.

[3]  Xiaobo Li,et al.  Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRalpha activation. , 2010, Biochimica et biophysica acta.

[4]  M. Chopp,et al.  Increasing tPA Activity in Astrocytes Induced by Multipotent Mesenchymal Stromal Cells Facilitate Neurite Outgrowth after Stroke in the Mouse , 2010, PloS one.

[5]  G. Celano,et al.  Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. , 2009, International journal of oncology.

[6]  Chao-ke Tang,et al.  Mast cell degranulator compound 48–80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement , 2009, Chinese medical journal.

[7]  D. Ribatti,et al.  Inflammatory angiogenesis in atherogenesis—a double-edged sword , 2008, Annals of medicine.

[8]  Z. Ou,et al.  RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion , 2007, Clinical & Experimental Metastasis.

[9]  P. Kovanen.  Mast cells: multipotent local effector cells in atherothrombosis , 2007, Immunological reviews.

[10]  L. Yin,et al.  Tryptase activates PKB in inflammatory reaction in ECV304 cells. , 2006, Biochimica et biophysica acta.

[11]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[12]  S. Takai,et al.  The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  A. Matsumori,et al.  Mast Cell Tryptase in Mast Cell Granules Enhances MCP-1 and Interleukin-8 Production in Human Endothelial Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Sajantila,et al.  Mast Cells in Neovascularized Human Coronary Plaques Store and Secrete Basic Fibroblast Growth Factor, a Potent Angiogenic Mediator , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  A. Horrevoets.  Plasminogen activator inhibitor 1 (PAI‐1): in vitro activities and clinical relevance , 2004, British journal of haematology.

[16]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[17]  E. Conway.  Angiogenesis: A link to Thrombosis in Athero-thrombotic Disease , 2003, Pathophysiology of Haemostasis and Thrombosis.

[18]  B. Sobel,et al.  Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[19]  M. Nishibori,et al.  Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. , 2003, Cellular signalling.

[20]  E. Crivellato,et al.  Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia , 2003, Leukemia.

[21]  A. Ben-Yehudah,et al.  Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-α, IL-6 and IL-1β: possible relevance to multiple sclerosis , 2003, Journal of Neuroimmunology.

[22]  Mark M. Kockx,et al.  Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. von Eckardstein,et al.  Mast Cell Tryptase Degrades HDL and Blocks Its Function as an Acceptor of Cellular Cholesterol , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[24]  A. Luttun,et al.  Lack of Plasminogen Activator Inhibitor-1 Promotes Growth and Abnormal Matrix Remodeling of Advanced Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[25]  K. Moulton.  ArePlaque angiogenesis and atherosclerosis , 2001 .

[26]  V. Salomaa,et al.  Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[27]  S. Holgate,et al.  Human mast cell tryptase stimulates the release of an IL‐8‐dependent neutrophil chemotactic activity from human umbilical vein endothelial cells (HUVEC) , 2000, Clinical and experimental immunology.

[28]  D. Woolley,et al.  Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries , 1999, The Journal of pathology.

[29]  G. Angelini,et al.  Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[30]  S. Ren,et al.  Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. , 1997, The Journal of clinical investigation.

[31]  D. Woolley,et al.  MAST CELL DISTRIBUTION, ACTIVATION, AND PHENOTYPE IN ATHEROSCLEROTIC LESIONS OF HUMAN CAROTID ARTERIES , 1997, The Journal of pathology.

[32]  J. Flack,et al.  A micro-enzymatic method to measure cholesterol and triglyceride in lipoprotein subfractions separated by density gradient ultracentrifugation from 200 microliters of plasma or serum. , 1991, Journal of lipid research.

[33]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[34]  Y. Itoh,et al.  Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function. , 2005, Journal of pharmacological sciences.